HOME >> MEDICINE >> NEWS
Now is a pivotal point in history to abolish state execution

This is a pivotal point in history for countries to consider evidence that demonstrates the barbarity of lethal injection and abolish state execution, states an editorial in this week's issue of The Lancet.

Last year The Lancet published a paper, which found that despite a theoretically lethal dose of the barbiturate thiopental, given before the injection of pancuronium to paralyse breathing muscles and potassium chloride to stop the heart, 21 of 49 executed US inmates had postmortem thiopental concentrations consistent with consciousness (See Lancet 2005; 365: 141214). Now, a Californian judge--Judge Jeremy Fogel--has ruled that the state must either rely solely on thiopental, or else have a qualified individual confirm unconsciousness before the injection of pancuronium and potassium chloride, in order to avoid excessive pain. As a result, Californian officials have had to postpone the execution of a convicted murderer by lethal injection after they were unable to find medical personnel willing to participate. Involvement in executions contradicts the principles of many professional organisations in the US, including the American Medical Association.

The Lancet comments: "This is a pivotal point in history. A moment when individuals, like Judge Fogel, and the anaesthetists who refused to participate, have given voice to their conscience. They have articulated the concerns of an increasing number of Americans, whose support for capital punishment has dropped from 80% to 64% in the past decade. It is a voice to be heeded. As Judge Fogel noted, the Eighth Amendment has been interpreted as prohibiting punishments that are 'incompatible with the evolving standards of decency that mark the progress of a maturing society'. In 2004, China, Iran, Vietnam, and the USA accounted for 97% of the world's executions. From which of these countries will a mature society take the lead, and abolish the atrocity of state execution?"


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
2-Mar-2006


Page: 1

Related medicine news :

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
2. Approval to start US BTT pivotal trial
3. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
4. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
5. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
6. Metabolic syndrome points to heart health
7. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
8. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
9. System to pinpoint airline passengers who contaminate cabins
10. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
11. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology:
Cached News: